Earnings Alerts

Largan Precision (3008) Earnings Surge: September Sales Hit NT$6.52 Billion, Up 17.1%

  • September Sales Performance: Largan reported sales of NT$6.52 billion in September.
  • Sales Growth: There was a 17.1% increase in sales compared to the previous period.
  • Analyst Recommendations: The company received 22 “buy” recommendations.
  • Hold Ratings: Four analysts recommended holding the stock.
  • No Sell Recommendations: There were zero “sell” recommendations for Largan.

A look at Largan Precision Smart Scores

FactorScoreMagnitude
Value4
Dividend4
Growth4
Resilience5
Momentum3
OVERALL SMART SCORE4.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts foresee a promising long-term trajectory for Largan Precision, a company known for manufacturing optical lens modules and optoelectronic components. With robust scores across various indicators, including a solid 4 in Value, Dividend, and Growth, as well as a top-notch 5 in Resilience, the company appears well-positioned for sustained success. Largan Precision‘s strong performance in these key areas signifies its potential for continued growth and stability in the market.

While Largan Precision shows strength in several aspects, such as its Resilience score of 5 reflecting its ability to weather market challenges, there are areas for development indicated by a slightly lower Momentum score of 3. Nevertheless, the overall positive outlook based on the Smartkarma Smart Scores bodes well for investors eyeing a company with solid fundamentals and growth potential within the optoelectronics industry. Largan Precision‘s diverse product line catering to various tech sectors further highlights its adaptability and market relevance.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars